736 related articles for article (PubMed ID: 32522631)
1. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
[TBL] [Abstract][Full Text] [Related]
2. Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease.
Paron F; Dardis A; Buratti E
J Biotechnol; 2020 Jul; 318():20-30. PubMed ID: 32387451
[TBL] [Abstract][Full Text] [Related]
3. Targeting defective sphingosine kinase 1 in Niemann-Pick type C disease with an activator mitigates cholesterol accumulation.
Newton J; Palladino END; Weigel C; Maceyka M; Gräler MH; Senkal CE; Enriz RD; Marvanova P; Jampilek J; Lima S; Milstien S; Spiegel S
J Biol Chem; 2020 Jul; 295(27):9121-9133. PubMed ID: 32385114
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics study with mutation shows that N-terminal domain structural re-orientation in Niemann-Pick type C1 is required for proper alignment of cholesterol transport.
Yoon HJ; Jeong H; Lee HH; Jang S
J Neurochem; 2021 Mar; 156(6):967-978. PubMed ID: 32880929
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.
Torres S; Matías N; Baulies A; Nuñez S; Alarcon-Vila C; Martinez L; Nuño N; Fernandez A; Caballeria J; Levade T; Gonzalez-Franquesa A; Garcia-Rovés P; Balboa E; Zanlungo S; Fabrías G; Casas J; Enrich C; Garcia-Ruiz C; Fernández-Checa JC
Redox Biol; 2017 Apr; 11():60-72. PubMed ID: 27888692
[TBL] [Abstract][Full Text] [Related]
6. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
[TBL] [Abstract][Full Text] [Related]
7. Niemann-Pick type C disease: cellular pathology and pharmacotherapy.
Wheeler S; Sillence DJ
J Neurochem; 2020 Jun; 153(6):674-692. PubMed ID: 31608980
[TBL] [Abstract][Full Text] [Related]
8. Overview of clinical, molecular, and therapeutic features of Niemann-Pick disease (types A, B, and C): Focus on therapeutic approaches.
Hosseini K; Fallahi J; Razban V; Sirat RZ; Varasteh M; Tarhriz V
Cell Biochem Funct; 2024 Jun; 42(4):e4028. PubMed ID: 38715125
[TBL] [Abstract][Full Text] [Related]
9. Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-Pick disease type C.
Zhou S; Davidson C; McGlynn R; Stephney G; Dobrenis K; Vanier MT; Walkley SU
Am J Pathol; 2011 Aug; 179(2):890-902. PubMed ID: 21708114
[TBL] [Abstract][Full Text] [Related]
10. δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders.
Xu M; Liu K; Swaroop M; Porter FD; Sidhu R; Firnkes S; Ory DS; Marugan JJ; Xiao J; Southall N; Pavan WJ; Davidson C; Walkley SU; Remaley AT; Baxa U; Sun W; McKew JC; Austin CP; Zheng W
J Biol Chem; 2012 Nov; 287(47):39349-60. PubMed ID: 23035117
[TBL] [Abstract][Full Text] [Related]
11. Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin.
Vance JE; Karten B
J Lipid Res; 2014 Aug; 55(8):1609-21. PubMed ID: 24664998
[TBL] [Abstract][Full Text] [Related]
12. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
Newton J; Hait NC; Maceyka M; Colaco A; Maczis M; Wassif CA; Cougnoux A; Porter FD; Milstien S; Platt N; Platt FM; Spiegel S
FASEB J; 2017 Apr; 31(4):1719-1730. PubMed ID: 28082351
[TBL] [Abstract][Full Text] [Related]
13. Endo-lysosomal dysfunction and neuronal-glial crosstalk in Niemann-Pick type C disease.
Malara M; Prestel M; Tahirovic S
Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220388. PubMed ID: 38368932
[TBL] [Abstract][Full Text] [Related]
14. The Niemann-Pick type diseases - A synopsis of inborn errors in sphingolipid and cholesterol metabolism.
Pfrieger FW
Prog Lipid Res; 2023 Apr; 90():101225. PubMed ID: 37003582
[TBL] [Abstract][Full Text] [Related]
15. Niemann-Pick Disease Type C: from molecule to clinic.
Tang Y; Li H; Liu JP
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):132-40. PubMed ID: 19566836
[TBL] [Abstract][Full Text] [Related]
16. Niemann-Pick type C disease: The atypical sphingolipidosis.
Newton J; Milstien S; Spiegel S
Adv Biol Regul; 2018 Dec; 70():82-88. PubMed ID: 30205942
[TBL] [Abstract][Full Text] [Related]
17. GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice.
van der Lienden MJC; Aten J; Marques ARA; Waas ISE; Larsen PWB; Claessen N; van der Wel NN; Ottenhoff R; van Eijk M; Aerts JMFG
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802460
[TBL] [Abstract][Full Text] [Related]
18. Different Trafficking Phenotypes of Niemann-Pick C1 Gene Mutations Correlate with Various Alterations in Lipid Storage, Membrane Composition and Miglustat Amenability.
Brogden G; Shammas H; Walters F; Maalouf K; Das AM; Naim HY; Rizk S
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204338
[TBL] [Abstract][Full Text] [Related]
19. Genistein Activates Transcription Factor EB and Corrects Niemann-Pick C Phenotype.
Argüello G; Balboa E; Tapia PJ; Castro J; Yañez MJ; Mattar P; Pulgar R; Zanlungo S
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921734
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological In Vitro Profile of Neuronal Differentiated Cells Derived from Niemann-Pick Disease Type C2 Patient-Specific iPSCs Carrying the
Liedtke M; Völkner C; Jürs AV; Peter F; Rabenstein M; Hermann A; Frech MJ
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
